Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE quetiapine rapid versus conventional dose escalation in acute schizophrenia
2004-005122-45Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Oct 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-005122-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005122-45.